Ventilator-Associated Pneumonia in Critically Ill Patients With COVID-19

Mailis Maes; Ellen Higginson; Joana Pereira-Dias; Martin D. Curran; Surendra Parmar; Fahad Khokhar; Delphine Cuchet-Lourenco; Janine Lux; Sapna Sharma-Hajela; Benjamin Ravenhill; Islam Hamed; Laura Heales; Razeen Mahroof; Amelia Solderholm; Sally Forrest; Sushmita Sridhar; Nicholas M. Brown; Stephen Baker; Vilas Navapurkar; Gordon Dougan; Josfin Bartholdson Scott; Andrew Conway Morris

Disclosures

Crit Care. 2021;25(25) 

In This Article

Conclusion

COVID-19 makes people more susceptible to developing VAP, partly but not entirely due to the increased duration of ventilation. The change in lung microbiome and causes of secondary infection are similar to those seen in critically ill patients ventilated for other reasons. Careful sampling of the respiratory tract whilst minimising contamination from the proximal tract, in combination with sensitive diagnostic testing to reduce the risk of false negative cultures will aid antimicrobial optimisation in patients with COVID-19.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....